Evaluating the Sensitivity of Hybridization-based Epigenotyping Using a Methyl Binding Domain Protein
Overview
Affiliations
Hypermethylation of CpG islands in gene promoter regions has been shown to be a predictive biomarker for certain diseases. Most current methods for methylation profiling are not well-suited for clinical analysis. Here, we report the development of an inexpensive device and an epigenotyping assay with a format conducive to multiplexed analysis.
Substituent Effects of Fluorescein on Photoredox Initiating Performance under Visible Light.
Choi W, Jung Y, Kim M, Kim H, Li J, Ko H ACS Omega. 2023; 8(43):40277-40286.
PMID: 37929095 PMC: 10620908. DOI: 10.1021/acsomega.3c04324.
Goto A, Yoshida W Anal Bioanal Chem. 2023; 415(12):2329-2337.
PMID: 36961575 DOI: 10.1007/s00216-023-04657-z.
Microfluidic epigenomic mapping technologies for precision medicine.
Deng C, Naler L, Lu C Lab Chip. 2019; 19(16):2630-2650.
PMID: 31338502 PMC: 6697104. DOI: 10.1039/c9lc00407f.
Tam B, Hao Y, Sikes H Biotechnol Prog. 2018; 34(6):1589-1595.
PMID: 29693329 PMC: 6202278. DOI: 10.1002/btpr.2644.
Engineering affinity agents for the detection of hemi-methylated CpG sites in DNA.
Tarn B, Sung K, Sikes H Mol Syst Des Eng. 2017; 1(3):273-277.
PMID: 28580176 PMC: 5450655. DOI: 10.1039/C6ME00073H.